« Return to News | Awards & Advancement

Victoria University launches Clinical Research Diploma

Wednesday, July 14, 2010 08:30 AM

Victoria University has launched a new post-graduate diploma in clinical research, claiming to be the only qualification of its kind in New Zealand, as part of a wider partnership on research, teaching and technology transfer with the Capital & Coast District Health Board (C&C DHB). The diploma is a distance learning course that will provide clinical researchers with, among other things, the capabilities to pursue drug development and conduct clinical trials, and will be taught mostly online by the university’s staff, together with clinicians from the C&C DHB and the Medical Research Institute of New Zealand. According to the university, its Postgraduate Diploma in Clinical Research, which begins in July, “takes the best of both the academic and clinical health worlds to strengthen clinical research.” U.S.-based CRO PRA International recently opened in New Zealand, saying the country was a key location for clinical studies in skin cancer, multiple sclerosis and asthma. PRA cited traditionally high recruitment rates across major therapeutic areas such as cardiology, respiratory diseases and gastrointestinal conditions; an efficient regulatory environment; and counter-seasonality for trials involving allergies or influenza.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.